Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prediction of long-term survival after liver transplantation for familial transthyretin amyloidosis.
Algalarrondo V, Antonini T, Théaudin M, Ducot B, Lozeron P, Chemla D, Benmalek A, Lacroix C, Azoulay D, Castaing D, Cauquil C, Rouzet F, Dinanian S, Eliahou L, Le Guludec D, Samuel D, Slama MS, Adams D. Algalarrondo V, et al. Among authors: eliahou l. J Am Coll Cardiol. 2015 Nov 10;66(19):2154-2156. doi: 10.1016/j.jacc.2015.08.870. J Am Coll Cardiol. 2015. PMID: 26541929 Free article. No abstract available.
Indications of anti-inflammatory drugs in cardiac diseases.
Algalarrondo V, Boycott H, Eliahou L, Mabille M, Slama MS. Algalarrondo V, et al. Among authors: eliahou l. Antiinflamm Antiallergy Agents Med Chem. 2013;12(1):3-13. doi: 10.2174/1871523011312010003. Antiinflamm Antiallergy Agents Med Chem. 2013. PMID: 23286286 Review.
Cardiac Dysautonomia Predicts Long-Term Survival in Hereditary Transthyretin Amyloidosis After Liver Transplantation.
Algalarrondo V, Antonini T, Théaudin M, Chemla D, Benmalek A, Lacroix C, Castaing D, Cauquil C, Dinanian S, Eliahou L, Samuel D, Adams D, Le Guludec D, Slama MS, Rouzet F. Algalarrondo V, et al. Among authors: eliahou l. JACC Cardiovasc Imaging. 2016 Dec;9(12):1432-1441. doi: 10.1016/j.jcmg.2016.07.008. Epub 2016 Nov 9. JACC Cardiovasc Imaging. 2016. PMID: 27838303 Free article.
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.
Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, Sultan MB, Rapezzi C; ATTR-ACT Study Investigators. Maurer MS, et al. N Engl J Med. 2018 Sep 13;379(11):1007-1016. doi: 10.1056/NEJMoa1805689. Epub 2018 Aug 27. N Engl J Med. 2018. PMID: 30145929 Free article. Clinical Trial.
Cause of death analysis and temporal trends in survival after liver transplantation for transthyretin familial amyloid polyneuropathy.
Algalarrondo V, Antonini T, Théaudin M, Chemla D, Benmalek A, Castaing D, Cauquil C, Rouzet F, Mika D, Duong E, Dinanian S, Eliahou L, Le Guludec D, Samuel D, Adams D, Slama MS. Algalarrondo V, et al. Among authors: eliahou l. Amyloid. 2018 Dec;25(4):253-260. doi: 10.1080/13506129.2018.1550061. Epub 2019 Jan 11. Amyloid. 2018. PMID: 30632809
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study.
Adams D, Polydefkis M, González-Duarte A, Wixner J, Kristen AV, Schmidt HH, Berk JL, Losada López IA, Dispenzieri A, Quan D, Conceição IM, Slama MS, Gillmore JD, Kyriakides T, Ajroud-Driss S, Waddington-Cruz M, Mezei MM, Planté-Bordeneuve V, Attarian S, Mauricio E, Brannagan TH 3rd, Ueda M, Aldinc E, Wang JJ, White MT, Vest J, Berber E, Sweetser MT, Coelho T; patisiran Global OLE study group. Adams D, et al. Lancet Neurol. 2021 Jan;20(1):49-59. doi: 10.1016/S1474-4422(20)30368-9. Epub 2020 Nov 16. Lancet Neurol. 2021. PMID: 33212063 Clinical Trial.
29 results